Biogen slashes Aduhelm price in half, foreshadows significant layoffs as sales continue to stagnate
In a surprise move, Biogen announced Monday that it will cut in half the price of its controversial Alzheimer’s drug Aduhelm, slashing the cost from $56,000 to $28,000. The sudden discount marks a...
#turnaround #layoffs #biogen #alzheimer #aduhelm